Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Paramyxoviridae Infections”

456 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 456 results

Large-scale testing (Phase 3)Study completedNCT00384397
What this trial is testing

2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,128
Testing effectiveness (Phase 2)WithdrawnNCT04267822
What this trial is testing

Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV

Who this might be right for
RSV InfectionStem Cell Transplant ComplicationsLower Resp Tract Infection
Pfizer
Not applicableUnknownNCT03170765
What this trial is testing

Randomized Controlled Trial of Measles Vaccination Schedule

Who this might be right for
MEASLES DISEASE
Post Graduate Institute of Medical Education and Research, Chandigarh 120
Early research (Phase 1)Study completedNCT03596801
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Ended earlyNCT02890381
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Not applicableNot Yet RecruitingNCT07643688
What this trial is testing

Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections

Who this might be right for
SARS CoV 2 InfectionRSV InfectionsInfluenza Infection
Fabiana Sherine Ganem dos Santos 150
Not applicableStudy completedNCT05592756
What this trial is testing

Secondary Attack Rate Measles Vaccine In Second Situation Contacts Cases Confirmed

Who this might be right for
Measles
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) 2,964
Testing effectiveness (Phase 2)Looking for participantsNCT07092865
What this trial is testing

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 184
Large-scale testing (Phase 3)Study completedNCT04938830
What this trial is testing

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

Who this might be right for
RSV Infection
Merck Sharp & Dohme LLC 1,003
Early research (Phase 1)Study completedNCT02668367
What this trial is testing

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

Who this might be right for
PharmacokineticsHealthy Volunteers
Biota Pharmaceuticals, Inc. 36
Not applicableStudy completedNCT01754428
What this trial is testing

Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
Gilead Sciences 2,432
Large-scale testing (Phase 3)Study completedNCT00127010
What this trial is testing

Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases

Who this might be right for
MeaslesRubellaMumps+1 more
GlaxoSmithKline
Early research (Phase 1)Study completedNCT02794870
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Post-approval studies (Phase 4)UnknownNCT05952505
What this trial is testing

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Two Attenuated Vaccines

Who this might be right for
SARS-CoV-2 InfectionVaricellaMeasles+2 more
Shanghai Municipal Center for Disease Control and Prevention 540
Early research (Phase 1)Study completedNCT05970744
What this trial is testing

Evaluation of RSV/Flu-01E Vaccine for the Prevention of RSV Infection in Volunteers Aged 18 to 59 Years and Over 60 Years

Who this might be right for
Respiratory Syncytial Virus Infections
Tatyana Zubkova 60
Large-scale testing (Phase 3)Looking for participantsNCT06955728
What this trial is testing

A Clinical Trial on Safety in Pregnant Women and How Well the Infant is Protected Against RSV-associated Lower Respiratory Tract Infection When the Pregnant Woman Receives the Approved RSV Vaccine Compared to a Placebo.

Who this might be right for
RSV InfectionsRSV ImmunisationPreterm Labour
University of Witwatersrand, South Africa 13,000
Testing effectiveness (Phase 2)Study completedNCT02360475
What this trial is testing

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 507
Not applicableUnknownNCT05928507
What this trial is testing

FINDER® Instrument and FINDER® FLU A/B, RSV, SARS-CoV-2 Test Clinical Evaluation Protocol

Who this might be right for
Influenza AInfluenza Type BSARS CoV 2 Infection+1 more
Baebies, Inc. 2,500
Testing effectiveness (Phase 2)Study completedNCT00352898
What this trial is testing

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Who this might be right for
MumpsRubellaMeasles+1 more
GlaxoSmithKline 400
Early research (Phase 1)Study completedNCT01909843
What this trial is testing

ALX-0171 Safety Study in Adults With Hyperresponsive Airways

Who this might be right for
Respiratory Syncytial Virus Infection
Ablynx, a Sanofi company 24
Load More Results